Cytokinetics, Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/02/2025 | 15.56 M | $625.51 M | 0.61% | 13.13% |
| VANGUARD GROUP INC | 05/09/2025 | 11.85 M | $476.23 M | -0.56% | 10.00% |
| FMR LLC | 05/12/2025 | 10.32 M | $414.61 M | -4.43% | 8.71% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 9.96 M | $400.10 M | -7.41% | 8.40% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 7.99 M | $321.07 M | 1.27% | 6.74% |
| STATE STREET CORP | 05/15/2025 | 6.09 M | $244.56 M | -1.34% | 5.14% |
| DEEP TRACK CAPITAL, LP | 05/15/2025 | 3.07 M | $123.54 M | 22.95% | 2.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.94 M | $118.08 M | 3.38% | 2.48% |
| RTW INVESTMENTS, LP | 05/15/2025 | 2.72 M | $109.36 M | 0.00% | 2.30% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 2.70 M | $108.63 M | 1,133.51% | 2.28% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 2.70 M | $108.51 M | 342.62% | 2.28% |
| VESTAL POINT CAPITAL, LP | 05/15/2025 | 2.59 M | $104.11 M | 10.24% | 2.19% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 2.46 M | $98.70 M | 11.79% | 2.07% |
| UBS GROUP AG | 05/13/2025 | 2.13 M | $85.77 M | 77.56% | 1.80% |
| MARSHALL WACE, LLP | 05/15/2025 | 2.03 M | $81.54 M | -5.78% | 1.71% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.99 M | $80.14 M | -24.04% | 1.68% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 1.96 M | $78.91 M | 2.32% | 1.65% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 1.72 M | $69.25 M | 914.04% | 1.45% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 1.52 M | $61.23 M | -4.51% | 1.29% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 1.51 M | $60.65 M | -4.72% | 1.27% |
| NORTHERN TRUST CORP | 05/13/2025 | 1.45 M | $58.17 M | -1.64% | 1.22% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 1.36 M | $54.78 M | 13.07% | 1.15% |
| JPMORGAN CHASE & CO | 05/12/2025 | 1.33 M | $53.27 M | -18.10% | 1.12% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.31 M | $52.76 M | -1.67% | 1.11% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 05/09/2025 | 1.31 M | $52.66 M | 2.37% | 1.11% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.26 M | $50.50 M | 27.02% | 1.06% |
| CAPITAL INTERNATIONAL INVESTORS | 05/12/2025 | 1.17 M | $46.95 M | 6.56% | 0.99% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.15 M | $46.24 M | -16.12% | 0.97% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2025 | 1.10 M | $44.21 M | 10.00% | 0.93% |
| BROWN ADVISORY INC | 04/30/2025 | 1.09 M | $43.66 M | 0.92% | 0.92% |
| JANUS HENDERSON GROUP PLC | 05/15/2025 | 1.06 M | $45.67 M | 3.19% | 0.89% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 1.02 M | $41.13 M | -22.00% | 0.86% |
| MORGAN STANLEY | 05/15/2025 | 1.01 M | $40.66 M | -19.25% | 0.85% |
| MELQART ASSET MANAGEMENT (UK) LTD | 05/15/2025 | 999.45 K | $40.17 M | -12.05% | 0.84% |
| RP MANAGEMENT, LLC | 05/02/2025 | 980.39 K | $39.40 M | 0.00% | 0.83% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 870.97 K | $35.00 M | -2.55% | 0.74% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 858.66 K | $34.51 M | 100.00% | 0.72% |
| FISHER ASSET MANAGEMENT, LLC | 05/14/2025 | 793.46 K | $31.89 M | 28.71% | 0.67% |
| AMERIPRISE FINANCIAL INC | 05/14/2025 | 786.58 K | $31.61 M | 4.54% | 0.66% |
| JANE STREET GROUP, LLC | 05/19/2025 | 755.71 K | $30.37 M | 598.94% | 0.64% |
| JENNISON ASSOCIATES LLC | 05/05/2025 | 673.93 K | $27.09 M | 100.00% | 0.57% |
| PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 629.91 K | $25.32 M | 132.33% | 0.53% |
| ABRDN PLC | 05/13/2025 | 602.42 K | $24.21 M | 33.72% | 0.51% |
| SARISSA CAPITAL MANAGEMENT LP | 05/15/2025 | 600.00 K | $24.11 M | -28.04% | 0.51% |
| 05/15/2025 | 585.81 K | $23.54 M | 28.02% | 0.49% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 539.11 K | $21.67 M | 287.52% | 0.46% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 537.62 K | $21.61 M | -1.50% | 0.45% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 522.47 K | $21.00 M | 6.77% | 0.44% |
| INVESCO LTD. | 05/12/2025 | 501.88 K | $20.17 M | -3.07% | 0.42% |
| TD ASSET MANAGEMENT INC | 05/07/2025 | 446.83 K | $17.96 M | -14.83% | 0.38% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cytokinetics, Incorporated institutional Ownership - FAQ's
During the previous two years, 455 institutional investors and hedge funds held shares of Cytokinetics, Incorporated. The most heavily invested institutionals were:
BlackRock, Inc.: 15.56 M
VANGUARD GROUP INC: 11.85 M
FMR LLC: 10.32 M
T. Rowe Price Investment Management, Inc.: 9.96 M
WELLINGTON MANAGEMENT GROUP LLP: 7.99 M
STATE STREET CORP: 6.09 M
114.29% of Cytokinetics, Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 164.63 M shares in the last 24 months. This purchase volume represents approximately $5.65 B in transactions.